ICCC grants clearance to Santos – EMTV Online emtv.com.pg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emtv.com.pg Daily Mail and Mail on Sunday newspapers.
F. Hoffmann-La Roche Ltd: FDA accepts application for Roche's Port Delivery System with ranibizumab (PDS) for treatment of neovascular or wet age-related macular degeneration (nAMD) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The Q1 operating loss of $3.4M includes the impact of non-cash items including amortisation, depreciation and the impact of share-based compensation expenses. Adjusting for these non-cash items, the Company delivered $9.9M of EBITDA
3 for the quarter.
2 Non-cash items include amortisation of the acquired metreleptin and lomitapide intangible assets ($10.7M), amortisation of the inventory fair value step-up that was acquired at the acquisition date ($1.0M), depreciation and amortisation ($0.3M) and share based compensation expenses ($1.3M).
3 EBITDA is earnings before interest, tax, depreciation, amortisation and share based compensation expenses. To supplement Amryt s financial results presented in accordance with IFRS generally accepted accounting principles, the Company uses EBITDA as a key measure of company performance as the Company believes that this measure is most reflective of the operational profitability or loss of the Company and provides management and inve